Patient characteristics
| Baseline | 12 Months | 24 Months | 36 Months | |
|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
| *Completers at the time of this analysis. | ||||
| Number of patients | 116 | 116 | 71* | 40* |
| Female, No (%) | 87 (75) | 87 (75) | 55 (77) | 33 (83) |
| Age (years) | 56.6 (12.9) | 56.6 (12.9) | 55.5 (12.8) | 54.3 (11.8) |
| Disease duration (years) | 14.2 (9.1) | |||
| DAS28*(0–10) | 5.85 (1.08) | 3.42 (1.32) | 3.40 (1.22) | 3.52 (1.44) |
| HAQ score* (0–3) | 1.52 (0.61) | 1.13 (0.73) | 1.08 (0.75) | 1.09 (0.62) |
| ESR (mm/1st h) | 44.1 (26.5) | |||
| CRP (g/l) | 45.4 (37.8) | |||
| Previous DMARDs (n) | 4.2 (2.1) | |||
| Current DMARDs (n) | 0.9 (0.7) | |||